Tropic Biosciences develops high-performing tropical crop varieties using CRISPR gene editing and RNA interference to enhance disease resistance and reduce pesticide reliance. Their technology addresses the challenges of climate change and food security by improving the yield and resilience of staple crops like bananas, coffee, and rice.
Funding
$75.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Tropical crops like bananas, coffee, and rice face increasing threats from climate change, diseases, and pests, leading to reduced yields and increased reliance on pesticides. These challenges threaten the livelihoods of growers and the food security of populations that depend on these staple crops.
Solution
Tropic Biosciences utilizes CRISPR gene editing and RNA interference (RNAi) to develop high-performing tropical crop varieties with enhanced disease resistance and improved yields. Their proprietary gene editing platform, GEiGS®, combines the precision of gene editing with the versatility of gene silencing to improve the natural traits of crops. By increasing crop resilience and reducing the need for pesticides, Tropic Biosciences aims to make tropical agriculture more productive and sustainable.
Target Audience
The primary target audience includes tropical crop growers seeking to improve yields, reduce pesticide use, and enhance the resilience of their crops to climate change and diseases.
Features
- GEiGS® gene editing platform for targeted crop improvement
- CRISPR-mediated gene editing to enhance disease resistance
- RNAi technology to reduce reliance on pesticides
- Development of climate-resilient crop varieties
- Focus on improving the yield and quality of bananas, coffee, and rice